MoneyWorks4Me

The sales slipped to Rs. 5430.90 millions for the September 2024 quarter as against Rs. 5775.40 millions during the year-ago period.The Net Profit of the company registered a slight decline of -12.12% to Rs. 303.90  millions from Rs. 345.80 millions.Operating profit for the quarter ended September 2024 decreased to 599.20 millions as compared to 661.60 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 5430.90 5775.40 -5.96 10360.50 11691.70 -11.39 22669.10 24979.70 -9.25
Other Income 3.80 7.40 -48.65 4.90 13.90 -64.75 41.80 22.30 87.44
PBIDT 599.20 661.60 -9.43 1142.50 1387.20 -17.64 2703.10 2846.30 -5.03
Interest 71.70 75.50 -5.03 146.30 153.20 -4.50 301.60 325.30 -7.29
PBDT 527.50 586.10 -10.00 996.20 1234.00 -19.27 2401.50 2521.00 -4.74
Depreciation 118.60 117.80 0.68 235.70 235.30 0.17 476.70 472.90 0.80
PBT 408.90 468.30 -12.68 760.50 998.70 -23.85 1924.80 2048.10 -6.02
TAX 105.00 122.50 -14.29 187.50 257.50 -27.18 506.00 520.00 -2.69
Deferred Tax 20.00 12.50 60.00 25.00 20.00 25.00 10.00 -12.50 -180.00
PAT 303.90 345.80 -12.12 573.00 741.20 -22.69 1418.80 1528.10 -7.15
Equity 912.70 919.40 -0.73 919.40 926.00 -0.71 919.40 926.00 -0.71
PBIDTM(%) 11.03 11.46 -3.69 11.03 11.86 -7.06 11.92 11.39 4.65
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..